In the western medicine, there are many forms of medicines and therapies that have not yet been formally recognized by major government health organizations like the Food and Drug Administration (FDA). These therapies are also considered quite controversial by health-care workers within our western society. As such, the implications of these medicines from a health/economics view show that insurance agencies have not formally added them to policies. In this documentary, we will explain and analyze the function and purpose of stem cell therapy (STT) injections and the use of biologics, which is defined as the medication produced from our own blood and proteins. We will fill in the gaps with knowledge regarding regenerative medicine, such as the functions and properties of stem cells and its lack of standardization in therapeutics. After providing further knowledge on these topics, we will transition into the health/economic perspective encompassing insurance coverage, government funding, FDA regulation and its potential future.

In the western medicine, there are many forms of medicines and therapies that have not yet been formally recognized by major government health organizations like the Food and Drug Administration (FDA). These therapies are also considered quite controversial by health-care workers within our western society. As such, the implications of these medicines from a health/economics view show that insurance agencies have not formally added them to policies. In this documentary, we will explain and analyze the function and purpose of stem cell therapy (STT) injections and the use of biologics, which is defined as the medication produced from our own blood and proteins. We will fill in the gaps with knowledge regarding regenerative medicine, such as the functions and properties of stem cells and its lack of standardization in therapeutics. After providing further knowledge on these topics, we will transition into the health/economic perspective encompassing insurance coverage, government funding, FDA regulation and its potential future.

Poor medication adherence is a widespread healthcare issue that directly impacts the effectiveness of the medication and the overall health of the patient. Wellth is a smartphone application offered to users challenged with managing chronic conditions to improve medication adherence through daily reminders and monthly financial incentives to help members form healthy habits. The study examined the effects of financial incentives on the medication adherence of members according to their characteristics including their age, gender, and location of residence in addition to the health conditions they were battling during a 5-month Wellth program. In this study, adherence was defined as the percent of days the users checked in all their medications within a ±3-hour task window while timely adherence was when check-ins were submitted in a narrower window of ±1-hour. Wellth demonstrated both positive and negative relationships between specific patients and adherence. By comparing the findings with the existing literature, patterns were evaluated, and hypotheses were made. The severity of the member’s illness and vulnerability to consequences seemed to go be joint factors. The complexities of medication regimens, side effects, and symptoms associated with their health condition affected patient motivation. Economic factors including financial status, healthcare access, and level of knowledge could also be used as an explanation. This study is important because it helps develop and implement effective adherence programs for different kinds of patients by examining what type of patients for whom incentives work best using a mobile app. Essentially, this helps target features and design new programs for those who did not respond well to financial incentives.

The purpose of this study was to examine the demographic and geographic disparities in the incidence of newborn babies with Neonatal Abstinence Syndrome (NAS) in the United States from 2012 to 2015. Specifically, I examined the prevalence of NAS according to geographic location (i.e. urban versus rural) and race while also controlling for mother’s insurance type, median household income, and trends over time. Additional analyses explored the relationship between NAS and delivery method, birth weight, and neonatal candidiasis that causes sepsis. Understanding the disparities in NAS and birth outcomes during this period (2012-2015) can help better target interventions for combating the health and economic burdens of NAS since maternal opioid use has continued to rise since 2015. Additionally, existing research into geographic disparities in NAS have only been region-specific. This study expands the scope of this literature by considering urban versus rural disparities across the country.